MTOR and gastric cancer: Alisertib suppresses cell proliferation, promotes cell cycle arrest and autophagy, and activates the mitochondria-dependent apoptotic pathway in GC cells through PI3K/Akt/mTOR, p38 MAPK and AMPK signalling pathways [122].